- Trials with a EudraCT protocol (115)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
115 result(s) found for: Body identification.
Displaying page 1 of 6.
EudraCT Number: 2017-003673-34 | Sponsor Protocol Number: BioCellThyr | Start Date*: 2018-04-05 |
Sponsor Name:Oslo University Hospital, Department of Endocrinologi, Morbid Obesity and Preventive Medicine | ||
Full Title: Identification of non-responders to levothyroxine-therapy: development of biomarkers reflecting T4 and T3 action at the tissue level | ||
Medical condition: Women with dysregulated hypothyroidism | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000904-36 | Sponsor Protocol Number: IBS-DOTIG-ECM-2202 | Start Date*: 2022-05-09 | |||||||||||
Sponsor Name:Instituto de Investigación Biomédica de Salamanca | |||||||||||||
Full Title: Randomized clinical trial to evaluate the dose and administration time of indocyanine green in near-infrared fluorescent cholangiography during laparoscopic cholecystectomy. | |||||||||||||
Medical condition: Laparoscopic cholecystectomy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003343-11 | Sponsor Protocol Number: GLP1ALCOHOL | Start Date*: 2017-04-12 | |||||||||||
Sponsor Name:Psychiatric Centre Copenhagen | |||||||||||||
Full Title: Does Glucagon-like Peptide 1 (GLP-1) receptor stimulation reduce alcohol intake in patients with alcohol dependence? | |||||||||||||
Medical condition: Alcohol dependence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004979-39 | Sponsor Protocol Number: MSP-2017-1220 | Start Date*: 2020-08-06 |
Sponsor Name:Milestone Pharmaceuticals Inc. | ||
Full Title: An open-label, mass balance study to investigate the absorption, distribution, metabolism and excretion of [14C]-etripamil nasal spray after a single dose to healthy male subjects | ||
Medical condition: Paroxysmal supraventricular tachycardia (PSVT) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005788-28 | Sponsor Protocol Number: ICG1 | Start Date*: 2014-01-24 |
Sponsor Name:Landeskrankenhaus Fedkirch | ||
Full Title: Influence of Body Mass Index on the identification rate of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer | ||
Medical condition: A feasibility study of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000829-55 | Sponsor Protocol Number: PSILO4ALCO | Start Date*: 2020-12-16 | ||||||||||||||||
Sponsor Name:Psychiatric Centre Copenhagen | ||||||||||||||||||
Full Title: Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial. | ||||||||||||||||||
Medical condition: Alcohol Use Disorder | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001623-39 | Sponsor Protocol Number: Levo1010 | Start Date*: 2018-07-26 |
Sponsor Name:Verein zur Förderung der Forschung auf dem Gebiet der Arteriosklerose, Thrombose und vaskulären Biologie (ATVB) | ||
Full Title: Assessment of body composition changes after Levosimendan treatment in patients with advanced heart failure | ||
Medical condition: Advanced heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-009428-36 | Sponsor Protocol Number: CHUBX2008/34 | Start Date*: 2009-03-17 | |||||||||||
Sponsor Name:CHU de Bordeaux | |||||||||||||
Full Title: Imagerie moléculaire in vivo des transmissions cholinergique et dopaminergique dans les démences à corps de Lewy par tomographie d’émission monophotonique : Applications au diagnostic et à l’identi... | |||||||||||||
Medical condition: Démences à corps de Lewy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004445-42 | Sponsor Protocol Number: 1 | Start Date*: 2007-05-22 |
Sponsor Name:Institut for Pharmacology and Toxicology | ||
Full Title: Pharmacokinetics of Cetriaxon in bone | ||
Medical condition: hip replacement | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003898-42 | Sponsor Protocol Number: 2 | Start Date*: 2008-03-19 |
Sponsor Name:Institut for Pharmacology and Toxicology | ||
Full Title: Pharmacokinetica of levofloxacine in bone | ||
Medical condition: hip or knee replacement | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005488-25 | Sponsor Protocol Number: 8833 | Start Date*: 2017-02-02 |
Sponsor Name:UH Montpellier | ||
Full Title: Evaluation of the effectiveness of intradiscal injection of corticosteroids in the Modic I discopathies | ||
Medical condition: chronic low back pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004869-88 | Sponsor Protocol Number: HS2116100 | Start Date*: 2016-12-21 |
Sponsor Name:GlaxoSmithKline K.K. (GSK) | ||
Full Title: A multicenter, open-label study to evaluate preventive efficacy for herpes simplex virus infection and safety of 256U87 (valaciclovir hydrochloride) in adult and pediatric hematopoietic stem cell t... | ||
Medical condition: Herpes simplex virus (HSV) infection before and after hematopoietic stem cell transplantation. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2020-004115-27 | Sponsor Protocol Number: IIBSP-OXI-2020-102 | Start Date*: 2021-05-10 |
Sponsor Name:Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau | ||
Full Title: Identification and clinical relevance of oxytocin deficient status: randomized, crossover, placebo-controlled pathophysiological pilot study: GLP1 study | ||
Medical condition: Hypopituitarism | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001570-42 | Sponsor Protocol Number: AirGOs-2 | Start Date*: 2018-05-07 |
Sponsor Name:Helsinki University Hospital | ||
Full Title: Aggravated airway inflammation: research on genomics and optimal treatments (AirGOs) | ||
Medical condition: Acetylsalicylic acid (ASA-) exacerbated respiratory disease (AERD). | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004374-25 | Sponsor Protocol Number: 61528 | Start Date*: 2020-03-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA UDINE | |||||||||||||
Full Title: Thoracic duct identification with Indocyanine green fluorescence during minimally invasive esophagectomy with patient in prone position | |||||||||||||
Medical condition: Chylothorax is a serioso post-operative complication, which occurs in 2-12% of patients undergoing esophagectomy. Thoracic duct lesion leads to a reduction of body fluids and albumin resulting in h... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003974-33 | Sponsor Protocol Number: CE150171 | Start Date*: 2021-05-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA UDINE | |||||||||||||
Full Title: Thoracic duct identification with indocyanine green fluorescence during esophagectomy | |||||||||||||
Medical condition: Chylothorax is a serious post-operative complication, with occurs in 2-12% of patients undergoing esophagectomy. Thoracic duct lesion leads to a reduction of body fluids and albumin resulting in hy... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001566-15 | Sponsor Protocol Number: EIP19-NFD-501 | Start Date*: 2019-10-07 | |||||||||||
Sponsor Name:EIP Pharma Inc | |||||||||||||
Full Title: A Double-Blind, Placebo-Controlled 16-Week Study of the Cognitive Effects of the Oral P38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies (DLB) | |||||||||||||
Medical condition: Dementia with Lewy Bodies (DLB) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001511-20 | Sponsor Protocol Number: 1 | Start Date*: 2017-01-19 |
Sponsor Name:Institute for Pharmacology and Toxicology | ||
Full Title: Pharmacokinetica of Cefuroxime | ||
Medical condition: hip or knee replacement or spine bone surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001459-22 | Sponsor Protocol Number: BIA-PAR-DEPOT | Start Date*: 2015-02-20 |
Sponsor Name:Bial Industrial Farmacéutica S.A. | ||
Full Title: OPEN CLINICAL TRIAL, MULTICENTER, WITH SUBCUTANEOUS IMMUNOTHERAPY IN DEPOT PRESENTATION, IN PATIENTS WITH ALLERGY RHINOCONJUNCTIVITIS SENSITIZED TO PARIETARIA JUDAICA | ||
Medical condition: PATIENTS WITH RHINOCONJUNCTIVITIS SENSITISED TO PARIETARIA JUDAICA | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004829-16 | Sponsor Protocol Number: OSequIT | Start Date*: 2018-09-19 |
Sponsor Name:Fondazione Franco e Piera Cutino Onlus | ||
Full Title: Multicentric Randomized Clinical Trial of Deferiprone-Deferasirox Sequential Therapy versus Deferasirox or Deferiprone | ||
Medical condition: Diagnosis of transfusion-dependent beta thalassemia | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
